Authors:
Crul, M
van den Bongard, HJGD
Tibben, MM
van Tellingen, O
Sava, G
Schellens, JHM
Beijnen, JH
Citation: M. Crul et al., Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry, FRESEN J AN, 369(5), 2001, pp. 442-445
Authors:
Pacor, S
Vadori, M
Vita, F
Bacac, M
Soranzo, MR
Zabucchi, G
Sava, G
Citation: S. Pacor et al., Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A, ANTICANC R, 21(4A), 2001, pp. 2523-2530
Authors:
Bergamo, A
Zorzet, S
Cocchietto, M
Carotenuto, ME
Magnarin, M
Sava, G
Citation: A. Bergamo et al., Tumour cell uptake G(2)-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells, ANTICANC R, 21(3B), 2001, pp. 1893-1898
Authors:
Das, K
Couldwell, WT
Sava, G
Taddonio, RF
Citation: K. Das et al., Use of cylindrical titanium mesh and locking plates in anterior cervical fusion - Technical note, J NEUROSURG, 94(1), 2001, pp. 174-178
Authors:
Bergamo, A
Zorzet, S
Gava, B
Sorc, A
Alessio, E
Iengo, E
Sava, G
Citation: A. Bergamo et al., Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells, ANTI-CANC D, 11(8), 2000, pp. 665-672
Citation: M. Cocchietto et G. Sava, Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice, PHARM TOX, 87(5), 2000, pp. 193-197
Authors:
Magnarin, M
Bergamo, A
Carotenuto, ME
Zorzet, S
Sava, G
Citation: M. Magnarin et al., Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A, ANTICANC R, 20(5A), 2000, pp. 2939-2944
Authors:
Pacor, S
Magnarin, M
Carotenuto, ME
Spessotto, P
Zabucchi, G
Sava, G
Citation: S. Pacor et al., In vitro growth of TS/A adenocarcinoma and of the gene transfected TS/A-IL4 line on biological substrates, ANTICANC R, 20(1A), 2000, pp. 191-196
Authors:
Cocchietto, M
Salerno, G
Alessio, E
Mestroni, G
Sava, G
Citation: M. Cocchietto et al., Fate of the antimetastatic ruthenium complex ImH [trans-RuCl4(DMSO)Im] after acute i.v. treatment in mice, ANTICANC R, 20(1A), 2000, pp. 197-202
Authors:
Alessio, E
Iengo, E
Zorzet, S
Bergamo, A
Coluccia, M
Boccarelli, A
Sava, G
Citation: E. Alessio et al., Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na-2[{trans-RuCl4( Me2SO)}(2)(mu-L)] (L = ditopic, non-chelating aromatic N-ligand). A preliminary investigation, J INORG BIO, 79(1-4), 2000, pp. 173-177
Authors:
Zorzet, S
Bergamo, A
Cocchietto, M
Sorc, A
Gava, B
Alessio, E
Iengo, E
Sava, G
Citation: S. Zorzet et al., Lack of in vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of Matrigel invasion, may predict in vivo-selective antimetastasis activity of ruthenium complexes, J PHARM EXP, 295(3), 2000, pp. 927-933
Authors:
Pacor, S
Gagliardi, R
Di Daniel, E
Vadori, M
Sava, G
Citation: S. Pacor et al., In vitro down regulation of ICAM-1 and E-cadherin and in vivo reduction oflung metastases of TS/A adenocarcinoma by a lysozyme derivative, INT J MOL M, 4(4), 1999, pp. 369-375
Authors:
Sava, G
Clerici, K
Capozzi, I
Cocchietto, M
Gagliardi, R
Alessio, E
Mestroni, G
Perbellini, A
Citation: G. Sava et al., Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of theselective action investigated on mouse tumors, ANTI-CANC D, 10(1), 1999, pp. 129-138
Authors:
Sava, G
Gagliardi, R
Bergamo, A
Alessio, E
Mestroni, G
Citation: G. Sava et al., Treatment of metastases of solid mouse tumours by NAMI-A: Comparison with cisplatin, cyclophosphamide and dacarbazine, ANTICANC R, 19(2A), 1999, pp. 969-972
Authors:
Bergamo, A
Gagliardi, R
Scarcia, V
Furlani, A
Alessio, E
Mestroni, G
Sava, G
Citation: A. Bergamo et al., In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin, J PHARM EXP, 289(1), 1999, pp. 559-564